Form D — EtiraRX, Inc.
0001996442-26-000002 · filed May 14, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $3,000,003
- Total sold
- $2,277,533
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- EtiraRX, Inc.
- CIK
- 1996442
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3060 PEGASUS PARK DRIVE
DALLAS, TX 75247 - Phone
- 469-600-6603
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Russell Hayward · Executive OfficerDallas, TX Find on LinkedIn ↗
-
Ganesh Raj · Executive OfficerDallas, TX Find on LinkedIn ↗
-
Justin Stebbing · DirectorDallas, TX Find on LinkedIn ↗
-
Annalisa Jenkins · DirectorDallas, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗